We and others have previously shown that stimulating AR transcriptional programs in androgen-deprived prostate cancer cells using natural AR agonists such as testosterone and dihydrotestosterone (DHT) results in the production of numerous, transient DNA double-strand breaks (DSBs) that require DNA repair machinery for resolution [6–9]. Here, AR is linked to prostate carcinoma.